Next-Generation Cologuard Improves Colorectal Cancer Detection, False Positive Rates in BLUE-C

Thomas F. Imperiale, MD, discusses the pivotal findings showing improvements to the prior iteration of Cologuard, as well as bettered sensitivity and specificty relative to fecal immunochemical tests.

Related Keywords

Vancouver ,British Columbia ,Canada ,Thomasf Imperiale , ,Sciences Corp ,Indiana University Medical Center ,American College Of Gastroenterology ,American College ,Scientific Meeting ,Exact Sciences Corp ,Exact Sciences ,Cologaurd ,Stool Dna Test ,Colorectal Cancer ,Sensitivity ,Specificity ,Blue C ,Pacg ,